168 related articles for article (PubMed ID: 38548747)
1. FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression.
Liu Z; Meng X; Zhang Y; Sun J; Tang X; Zhang Z; Liu L; He Y
Int J Oral Sci; 2024 Mar; 16(1):26. PubMed ID: 38548747
[TBL] [Abstract][Full Text] [Related]
2. FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer.
Huang Y; Zhang HL; Li ZL; Du T; Chen YH; Wang Y; Ni HH; Zhang KM; Mai J; Hu BX; Huang JH; Zhou LH; Yang D; Peng XD; Feng GK; Tang J; Zhu XF; Deng R
Nat Commun; 2021 May; 12(1):2672. PubMed ID: 33976130
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin 7A promotes endothelial to mesenchymal transition through ATF3 mediated TGF-β2/Smad signaling.
Hong L; Li F; Tang C; Li L; Sun L; Li X; Zhu L
Cell Death Dis; 2020 Aug; 11(8):695. PubMed ID: 32826874
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis.
Xie J; Wang H
Arthritis Res Ther; 2017 Jan; 19(1):10. PubMed ID: 28109308
[TBL] [Abstract][Full Text] [Related]
5. Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival.
Tarullo SE; Hill RC; Hansen KC; Behbod F; Borges VF; Nelson AC; Lyons TR
Oncogene; 2020 Mar; 39(13):2772-2785. PubMed ID: 32020054
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.
Kinehara Y; Nagatomo I; Koyama S; Ito D; Nojima S; Kurebayashi R; Nakanishi Y; Suga Y; Nishijima-Futami Y; Osa A; Nakatani T; Kato Y; Nishide M; Hayama Y; Higashiguchi M; Morimura O; Miyake K; Kang S; Minami T; Hirata H; Iwahori K; Takimoto T; Takamatsu H; Takeda Y; Hosen N; Hoshino S; Shintani Y; Okumura M; Kumagai T; Nishino K; Imamura F; Nakatsuka SI; Kijima T; Kida H; Kumanogoh A
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568033
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells.
Ghofrani J; Lucar O; Dugan H; Reeves RK; Jost S
Eur J Immunol; 2019 Aug; 49(8):1153-1166. PubMed ID: 31016720
[TBL] [Abstract][Full Text] [Related]
8. PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy.
Xu Y; Gao Z; Hu R; Wang Y; Wang Y; Su Z; Zhang X; Yang J; Mei M; Ren Y; Li M; Zhou X
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34697216
[TBL] [Abstract][Full Text] [Related]
9. Vascular Semaphorin 7A Upregulation by Disturbed Flow Promotes Atherosclerosis Through Endothelial β1 Integrin.
Hu S; Liu Y; You T; Heath J; Xu L; Zheng X; Wang A; Wang Y; Li F; Yang F; Cao Y; Zhang H; van Gils JM; van Zonneveld AJ; Jo H; Wu Q; Zhang Y; Tang C; Zhu L
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):335-343. PubMed ID: 29269512
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer.
Elder AM; Tamburini BAJ; Crump LS; Black SA; Wessells VM; Schedin PJ; Borges VF; Lyons TR
Cancer Res; 2018 Nov; 78(22):6473-6485. PubMed ID: 30254150
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin.
Suzuki K; Okuno T; Yamamoto M; Pasterkamp RJ; Takegahara N; Takamatsu H; Kitao T; Takagi J; Rennert PD; Kolodkin AL; Kumanogoh A; Kikutani H
Nature; 2007 Apr; 446(7136):680-4. PubMed ID: 17377534
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 7A inhibits platelet production from CD34+ progenitor cells.
Jaimes Y; Gras C; Goudeva L; Buchholz S; Eiz-Vesper B; Seltsam A; Immenschuh S; Blasczyk R; Figueiredo C
J Thromb Haemost; 2012 Jun; 10(6):1100-8. PubMed ID: 22448926
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation.
Chiang WF; Cheng TM; Chang CC; Pan SH; Changou CA; Chang TH; Lee KH; Wu SY; Chen YF; Chuang KH; Shieh DB; Chen YL; Tu CC; Tsui WL; Wu MH
Oncogene; 2018 Jan; 37(1):116-127. PubMed ID: 28892050
[TBL] [Abstract][Full Text] [Related]
14. FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer.
Bastian K; Scott E; Elliott DJ; Munkley J
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466384
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis.
De Minicis S; Rychlicki C; Agostinelli L; Saccomanno S; Trozzi L; Candelaresi C; Bataller R; Millán C; Brenner DA; Vivarelli M; Mocchegiani F; Marzioni M; Benedetti A; Svegliati-Baroni G
Am J Pathol; 2013 Sep; 183(3):820-30. PubMed ID: 23850082
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin 7A protein variants differentially regulate T-cell activity.
Gras C; Eiz-Vesper B; Seltsam A; Immenschuh S; Blasczyk R; Figueiredo C
Transfusion; 2013 Feb; 53(2):270-83. PubMed ID: 22845496
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression.
Liu Y; Guo C; Li F; Wu L
Cell Biochem Funct; 2020 Jan; 38(1):58-65. PubMed ID: 31732974
[TBL] [Abstract][Full Text] [Related]
19. Anoikis resistance in mammary epithelial cells is mediated by semaphorin 7a.
Rutherford TR; Elder AM; Lyons TR
Cell Death Dis; 2021 Sep; 12(10):872. PubMed ID: 34561423
[TBL] [Abstract][Full Text] [Related]
20. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
